Klinikum der Universität Köln
13
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment reporting
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
Role: collaborator
Living Well, Dying Well. a Research Programme to Support Living Until the End
Role: collaborator
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort
Role: collaborator
3-Month Home-based Training With Whole Body Vibration (WBV) Device in Patients With Heart Failure and Preserved Ejection Fraction (GALILEO-HFpEF-HOME) (GALILEOHOME)
Role: lead
Observation of Acute Cardiopulmonary Effects in Healthy Individuals Performing Cardiopulmonary Exercise Test (CPX) During Whole Body Vibration (WBV)
Role: lead
3-Month Home-based Training With Whole Body Vibration Device in Patients With PAH (GALILEO-PAH-HOME)
Role: lead
Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy
Role: collaborator
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:
Role: collaborator
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control
Role: collaborator
Comparison of TOT 8/4 Versus TOT 6/3
Role: lead
Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women
Role: lead
Treatment of Urge Urinary Incontinence in Women After Failure of Cesa or Vasa
Role: lead
Training With Whole Body Vibration Device in Patients With PAH
Role: lead
All 13 trials loaded